News & Opinion
Top 10 Innovations
Cell & Molecular Biology
Disease & Medicine
Ecology & Environment
Genetics & Genomics
Pharma & Biotech
Image of the Day
Vision Restored: The Latest Technologies to Improve Sight
Anna Azvolinsky | Apr 10, 2018
Cell implants, gene therapy, even optogenetics are making headway in clinical trials to treat various forms of blindness.
Shoddy Preclinical Data Used in Clinical Trial Proposals
Kerry Grens | Apr 5, 2018
Applications for Phase 1 and 2 human studies in Germany frequently lack sufficient information about an intervention’s efficacy in animal experiments, according to a new study.
PARP Inhibitors Are Improving the Outlook of Hard-to-Treat Cancers
Vicki Brower | Apr 1, 2018
With three recent FDA approvals, and a number of Phase 3 trials ongoing, the drugs are seeing a surge in interest.
Recipients of Experimental Herpes Vaccine File Lawsuit
Catherine Offord | Mar 15, 2018
The suit claims that Rational Vaccines, the company of recently deceased researcher William Halford, violated US and international laws when it carried out the procedure.
Drug for Still’s Disease Shows Promise in Phase 2 Trial
Shawna Williams | Mar 1, 2018
Patients with the rare autoimmune condition, highlighted in the Oscar-nominated film
The Big Sick
, currently have limited treatment options.
New Automated Tool Monitors Clinical Trial Reporting
Diana Kwon | Feb 22, 2018
The watchdog website FDAAA TrialsTracker names and shames human studies that breach the FDA’s requirements for reporting results.
NIH’s New Rules Governing Human Research Go Into Effect
Jim Daley | Jan 25, 2018
More than 3,500 scientists had signed an open letter to NIH Director Francis Collins opposing the rules change.
New Federal Policy for Human Research Subjects Delayed
Diana Kwon | Jan 23, 2018
Both higher education and industry associations were advocating for a later implementation date for the Common Rule, which governs human studies.
CRISPR Trial for Cancer Patients Proposed
Katarina Zimmer | Jan 19, 2018
US researchers could become the first outside China to use the gene-editing technique in the clinic.
Investigation Questions Transparency for Failed TB Vax
Jef Akst | Jan 11, 2018
inquiry finds that researchers presented only select results from animal experiments when applying for funding and approval for human trials.